Antibiotic Prophylaxis for TEVAR
Reason given: Unable to enroll a sufficient number of patients
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- First Affiliated Hospital of Zhejiang University
- Trial code
- NCT05405790
- Record updated
- 25 September 2025
- Original description
The infection rate of thoracic endovascular aortic repair (TEVAR) is unknown due to a lack of epidemiological data. The rate currently available comes from researches conducted decades ago, when open surgery was the standard of care. Because of the potentially fatal consequences of a stent graft infection in the thoracic aorta, the investigators tend to prescribe antibiotic prophylaxis for at least three days. In this study, the investigators are going to collect data on patients receiving TEVAR in the past five years and provide the following information: a. the infection rate (MAGIC classification), b. the rate of fever, c. the results of the lab tests, such as the WBC count and C-reaction protein. d. risk factors associated with infection and fever.Read full original descriptionShow less
Antibiotic Prophylaxis for Thoracic EndoVascular Aortic Repair
The infection rate of thoracic endovascular aortic repair (TEVAR) is unknown due to a lack of epidemiological data. The rate currently available comes from researches conducted decades ago, when open surgery was the standard of care. Because of the potentially fatal consequences of a stent graft infection in the thoracic aorta, the investigators tend to prescribe antibiotic prophylaxis for at least three days. In this study, the investigators are going to collect data on patients receiving TEVAR in the past five years and provide the following information: a. the infection rate (MAGIC classification), b. the rate of fever, c. the results of the lab tests, such as the WBC count and C-reaction protein. d. risk factors associated with infection and fever.
Inclusion: Diagnosed with thoracic aortic diseases; Received TEVAR.
Exclusion: TEVAR combined with open surgery; Suspected infectious aortic disease, such as a mycotic aneurysm; Combined with immune deficiency disease or using hormone or immunosuppressant；; Endovascular aortic repair for abdominal aortic disease; History of open aortic surgery or heart surgery; Antibiotics have been used more than 24 hours before the operation; The treatment is for the complications of TEVAR, such as endoleak; Revascularization of visceral arteries during the TEVAR.